Insider · CIK 0001881190
Sarah Gheuens
officerdirector
Files at AGIO (AGIOS PHARMACEUTICALS, INC.), VRDN (Viridian Therapeutics, Inc.\DE). First filing Mar 4, 2025, latest Jul 11, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $832k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGIO: AGIOS PHARMACEUTICALS, INC.
AGIOOct 9, 2026 · close 31.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | AGIOS PHARMACEUTICALS, INC. | $453k 11,914 shares | -16% | +59% from low-37% from high | |
| 6Weak | AGIOS PHARMACEUTICALS, INC. | $140k 4,091 shares | -6% | +40% from low-44% from high | |
| 5Weak | AGIOS PHARMACEUTICALS, INC. | $98k 2,909 shares | -5% | +36% from low-46% from high | |
| 6Weak | AGIOS PHARMACEUTICALS, INC. | $142k 4,005 shares | -8% | +4% from low-46% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +11,914 | $25.01 | $298k | 73,185 | Jul 11, 2025 |
| Jul 9, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -11,067 | $37.93 | $420k | 62,118 | Jul 11, 2025 |
| Jul 9, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -847 | $38.76 | $33k | 61,271 | Jul 11, 2025 |
| Jul 9, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Stock options (right to buy)derivative10b5-1 | -11,914 | $0.00 | $0 | 32,086 | Jul 11, 2025 |
| Jul 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +8,374 | $0.00 | $0 | 65,362 | Jul 3, 2025 |
| Jul 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -4,091 | $34.17 | $140k | 61,271 | Jul 3, 2025 |
| Jul 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -8,374 | $0.00 | $0 | 8,375 | Jul 3, 2025 |
| Jul 1, 2025 | VRDN Viridian Therapeutics, Inc.\DE | AGrant or award Stock Option (Right to Buy)derivative | +21,000 | $0.00 | $0 | 21,000 | Jul 2, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +6,000 | $0.00 | $0 | 59,897 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -2,909 | $33.54 | $98k | 56,988 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -6,000 | $0.00 | $0 | 6,000 | Jun 26, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +3,833 | $0.00 | $0 | 48,235 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,137 | $35.54 | $40k | 47,098 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +4,000 | $0.00 | $0 | 51,098 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,187 | $35.54 | $42k | 49,911 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +5,667 | $0.00 | $0 | 55,578 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,681 | $35.54 | $60k | 53,897 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative10b5-1 | +12,000 | $0.00 | $0 | 12,000 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative10b5-1 | +43,500 | $0.00 | $0 | 43,500 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -3,833 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -4,000 | $0.00 | $0 | 4,000 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -5,667 | $0.00 | $0 | 11,333 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.